PURAPHARM INTERNATIONAL (H.K.) LIMITED 培力(香港)健康產品有限公司

Snapshot date:
exclude unknown removal dates

Main board

Name Age
in
2026
Position From Until
1 Chan, Abraham Yu Ling 陳宇齡 M 66 Ch, CEOChairman, Chief Executive Officer

Manager/adviser/other

Name Age
in
2026
Position From Until
1 Cheng, Frederick Hok Kai 鄭學啟 M 62 Sen MgrSenior Manager 2014-10

Webb-site Database - Powered By Linux Group

Back to top